Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renea A Taylor

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.
British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Cell Reports|January 6, 2021
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate CancerRayzel C Fernandes, John Toubia, Scott Townley, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Science Translational Medicine|February 8, 2019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancerMatthew J Watt, Ashlee K Clark, Luke A Selth, et al.
Gut Microbes|February 14, 2026
<i>Helicobacter pylori</i> induces the production of interleukin-37 to promote broad immunosuppression and enhance colonizationRishi Pathirana, Nagaja Capitani, Christopher McCrory, et al.
Cancer Research Communications|March 16, 2023
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate CancerMohammadreza Alizadeh-Ghodsi, Katie L Owen, Scott L Townley, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Genome Research|April 14, 2018
Enduring epigenetic landmarks define the cancer microenvironmentRuth Pidsley, Mitchell G Lawrence, Elena Zotenko, et al.
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
The Prostate|June 19, 2019
Establishing a cryopreservation protocol for patient-derived xenografts of prostate cancerLaura H Porter, Mitchell G Lawrence, Hong Wang, et al.
British Journal of Cancer|August 8, 2024
CDK9 inhibition inhibits multiple oncogenic transcriptional and epigenetic pathways in prostate cancerRazia Rahman, Muhammed H Rahaman, Adrienne R Hanson, et al.
Cell Reports|January 6, 2021
Post-transcriptional Gene Regulation by MicroRNA-194 Promotes Neuroendocrine Transdifferentiation in Prostate CancerRayzel C Fernandes, John Toubia, Scott Townley, et al.
European Urology Focus|April 12, 2025
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated VariantsMitchell G Lawrence, Shivakumar Keerthikumar, Scott L Townley, et al.
Science Translational Medicine|February 8, 2019
Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancerMatthew J Watt, Ashlee K Clark, Luke A Selth, et al.
Gut Microbes|February 14, 2026
<i>Helicobacter pylori</i> induces the production of interleukin-37 to promote broad immunosuppression and enhance colonizationRishi Pathirana, Nagaja Capitani, Christopher McCrory, et al.
Cancer Research Communications|March 16, 2023
Potent Stimulation of the Androgen Receptor Instigates a Viral Mimicry Response in Prostate CancerMohammadreza Alizadeh-Ghodsi, Katie L Owen, Scott L Townley, et al.
The Prostate|March 7, 2024
Defining the challenges and opportunities for using patient-derived models in prostate cancer researchW Nathaniel Brennen, Clémentine Le Magnen, Sofia Karkampouna, et al.
Genome Research|April 14, 2018
Enduring epigenetic landmarks define the cancer microenvironmentRuth Pidsley, Mitchell G Lawrence, Elena Zotenko, et al.
Nature Communications|January 10, 2017
Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectoriesRenea A Taylor, Michael Fraser, Julie Livingstone, et al.
Pageof 9